Position in FBIO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$328,347
+$215,492 QoQ
Shares Held
107,303
+165.3% QoQ
Ownership
0.292%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 55 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ACADIAN ASSET MANAGEMENT LLC holds $732,389,014 across 168 Biotechnology names. FBIO ranks #103 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
1,664,999 | $188,744,286 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,440 | $98,170,137 | |
| 3 | IMCR |
Immunocore Holdings plc
|
1,209,894 | $38,414,134 | |
| 4 | RIGL |
Rigel Pharmaceuticals Inc
|
591,686 | $23,146,756 | |
| 5 | EXEL |
Exelixis, Inc.
|
421,444 | $22,930,768 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
42,122 | $20,923,261 | |
| 7 | TBPH |
Theravance Biopharma, Inc.
|
1,174,910 | $19,973,470 | |
| 8 | PRTA |
Prothena Corp Public Ltd Co
|
2,010,645 | $19,684,214 |
All Filings in FBIO
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $328,347 | 107,303 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $112,855 | 40,450 | Shares | Defined | 2026-05-13 | |
| 2025-09-30 | $159,503 | 43,109 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $34,514 | 18,556 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $141,189 | 90,506 | Shares | Defined | 2025-05-21 | |
| 2024-12-31 | $376,518 | 185,477 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $699,762 | 482,595 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $474,538 | 277,508 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $584,116 | 292,058 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $391,865 | 130,188 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $311,903 | 1,075,531 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $591,542 | 1,075,531 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $838,231 | 1,022,233 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $500,650 | 758,561 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $652,362 | 758,561 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $571,672 | 680,563 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $577,582 | 424,693 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $394,600 | 157,840 | Shares | Defined | 2022-02-10 | |
| 2021-06-30 | $276,646 | 77,492 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $1,759,486 | 498,438 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $2,233,512 | 704,578 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $2,845,287 | 704,279 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $1,931,752 | 720,803 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $830,012 | 439,160 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||